Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research

OBJECTIVES: Review of efficacy and safety of Janus kinase (JAK) inhibition in immune-mediated inflammatory diseases (IMIDs). METHODS: A systematic literature research (SLR) of all publications on JAK inhibitors (JAKi) treatment published until March 2019 using MEDLINE, EMBASE and the Cochrane Librar...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:RMD Open
Autori principali: Kerschbaumer, Andreas, Smolen, Josef S, Nash, Peter, Doerner, Thomas, Dougados, Maxime, Fleischmann, Roy, Geissler, Klaus, McInnes, Iain B, Takeuchi, Tsutomu, Trauner, Michael, Winthrop, Kevin, de Wit, Maarten, Boehncke, Wolf-Henning, Falzon, Louise, van der Heijde, Desirée
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Autoimmunity
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856126/
https://ncbi.nlm.nih.gov/pubmed/33188136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001374
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi